JP4971597B2 - Antioxidant composition - Google Patents

Antioxidant composition Download PDF

Info

Publication number
JP4971597B2
JP4971597B2 JP2005085028A JP2005085028A JP4971597B2 JP 4971597 B2 JP4971597 B2 JP 4971597B2 JP 2005085028 A JP2005085028 A JP 2005085028A JP 2005085028 A JP2005085028 A JP 2005085028A JP 4971597 B2 JP4971597 B2 JP 4971597B2
Authority
JP
Japan
Prior art keywords
active oxygen
antioxidant
action
anserine
carnosine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2005085028A
Other languages
Japanese (ja)
Other versions
JP2006265161A (en
Inventor
延也 柳内
茂信 塩谷
聡 金沢
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tokai Bussan Co Ltd
Original Assignee
Tokai Bussan Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokai Bussan Co Ltd filed Critical Tokai Bussan Co Ltd
Priority to JP2005085028A priority Critical patent/JP4971597B2/en
Priority to TW094114124A priority patent/TWI307267B/en
Priority to US11/118,368 priority patent/US7727961B2/en
Publication of JP2006265161A publication Critical patent/JP2006265161A/en
Priority to US12/753,481 priority patent/US20100240599A1/en
Application granted granted Critical
Publication of JP4971597B2 publication Critical patent/JP4971597B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

本発明は、動物性天然エキス及び植物性天然エキスに由来する抗酸化能を有する特定の成分を組み合わせて成る組成物に関するものであり、更に詳しくは、多様な活性酸素種に対して有効に抗酸化能を発揮できる抗酸化組成物に関するものである。本発明は、人体内で発生する活性酸素による酸化ストレスを解消して広義の生活習慣病の予防、好適には、例えば、体内活性酸素が顕著に高い糖尿病患者の糖尿病関連疾患の予防に供せる抗酸化組成物を創製し、提供するものである。 The present invention relates to a composition comprising a combination of specific components having antioxidant ability derived from animal natural extracts and plant natural extracts, and more specifically, it effectively resists various reactive oxygen species. it relates antioxidative set Narubutsu can exhibit oxidizing ability. The present invention eliminates oxidative stress caused by active oxygen generated in the human body and prevents lifestyle-related diseases in a broad sense, preferably, for example, for prevention of diabetes-related diseases in diabetic patients whose active oxygen in the body is significantly high. An antioxidant composition is created and provided.

我国では、近年、高齢者人口の増加に伴う各種成人病の増加とその医療に関わる人的、経済的負担の増大が極めて深刻な問題として取り上げられている。生物の老化と病気の発生は言わば不可分の関係にあるので、高齢者が増加すれば病人の数も増えることは避けられないことである。そこで、人間の老化する速度を可能な限り遅くし、病気の発生を抑制することが重要になる。   In recent years, the increase in various adult diseases accompanying the increase in the elderly population and the increase in human and economic burdens related to medical care have been taken up as extremely serious problems. Since the aging of living organisms and the occurrence of diseases are inseparable, it is inevitable that the number of sick people will increase as the number of elderly people increases. Therefore, it is important to slow down the aging rate of humans as much as possible and suppress the occurrence of diseases.

人間が老化する第一の原因は、体を構成する細胞が組織再生のために分裂増殖する回数に限りがあることであり、細胞が何らかの傷害を受けることによって分裂増殖の回数が限界に到達し、組織再生能力が低下することである。そして、細胞を傷害する要因、例えば、紫外線や放射線の照射、薬物などの傷害、或いは生体内で発生する活性酸素による作用によって老化は促進される。特に、活性酸素は、酸素を利用してエネルギー代謝を行う生物では必然的に発生するものであり、この意味から、我々の老化は必然的に起こるともいえる。そこで、老化を遅延させ、老化に伴う疾病の発生を抑制する主要な対策としては、生体内で発生する活性酸素の有害作用を抑制することが重要になる。   The primary cause of human aging is the limited number of times the cells that make up the body divide and proliferate for tissue regeneration. The ability to regenerate the tissue is reduced. And aging is accelerated | stimulated by the effect | action by the factor which damages a cell, for example, irradiation of an ultraviolet-ray or a radiation, a medicine etc., or the active oxygen generated in the living body. In particular, active oxygen is inevitably generated in organisms that perform energy metabolism using oxygen, and in this sense, it can be said that our aging inevitably occurs. Therefore, as a main measure for delaying aging and suppressing the occurrence of diseases associated with aging, it is important to suppress the harmful effects of active oxygen generated in the living body.

これまで、各種の抗酸化剤が市場に供給されているが、これらのほとんどが単一成分、或いは単一原料により調製されたものであった。しかし、生体内で発生する活性酸素の種類は多様であり、具体的に例を挙げれば、体内に取り込まれた酸素ガスから発生するスーパーオキサイド(O )、O がスーパーオキサイドディスミューテース(SOD)と呼ぶ酵素により過酸化水素(H)が生成され、更に、これが遷移金属の触媒作用によって水酸化ラジカル(OH・)を発生させる。また、生体内に侵入した細菌類を殺菌するために白血球が活性酸素を生産するが、この中にはH以外に次亜塩素酸ラジカルや窒素酸化物ラジカルなどがある。 Until now, various antioxidants have been supplied to the market, but most of them were prepared from a single component or a single raw material. However, there are various types of active oxygen generated in a living body. Specifically, for example, superoxide (O 2 ) and O 2 generated from oxygen gas taken into the body are superoxide display. Hydrogen peroxide (H 2 O 2 ) is produced by an enzyme called TACE (SOD), which further generates hydroxyl radicals (OH.) By the catalytic action of transition metals. In addition, leukocytes produce active oxygen in order to sterilize bacteria that have entered the living body. Among them, there are hypochlorite radicals, nitrogen oxide radicals and the like in addition to H 2 O 2 .

一方、これらの活性酸素を消去するために各種抗酸化剤が用いられているが、これらの抗酸化剤がこれらの活性酸素全てに効果的なのか、或いは作用する活性酸素種が限定されるのか、十分に検討が行われて来なかった。本発明者らは、各種活性酸素の蛋白質酸化分解作用に対する抗酸化剤の作用を検討し、抗酸化剤にはそれらが作用する活性酸素の種類があり、生体内で全ての活性酸素に有効な抗酸化剤は極めて少ないことを明らかにして来た。   On the other hand, various antioxidants are used to eliminate these active oxygens, but are these antioxidants effective against all these active oxygens, or are the active oxygen species that act on them limited? There hasn't been enough consideration. The present inventors examined the action of antioxidants on the protein oxidative degradation action of various active oxygens, and there are types of active oxygens that they act on, and are effective against all active oxygens in vivo. It has been clarified that there are very few antioxidants.

すなわち、各種動物生体内に存在するペプチドのアンセリン、カルノシン、還元型グルタチオン(GSH)、硫黄含有アミノ酸、或いはアミノ酸類縁体は、次亜塩素酸ラジカル(ClO・)に対して、ビタミンC(L−アスコルビン酸、V.C)は、過酸化亜硝酸ラジカル(ONOO・)に対して、そして、ビタミンE(α−トコフェロール、V.E)は、水酸化ラジカル(OH・)に対して、強い抗酸化作用を持つており、生体内で発生する活性酸素の傷害を完全に除去するためには、これらを単一で使用するのではなく、これらを併用した抗酸化剤の組み合わせや組成が有効であることを確認した(特許文献1)。   That is, peptides such as anserine, carnosine, reduced glutathione (GSH), sulfur-containing amino acids, or amino acid analogs present in various animal living bodies are vitamin C (L-) against hypochlorous acid radicals (ClO.). Ascorbic acid, VC) is strong against peroxynitrite radicals (ONOO.), And vitamin E (α-tocopherol, VE) is strong against hydroxyl radicals (OH.). In order to completely remove injuries of active oxygen that occur in the living body, the combination and composition of antioxidants that use them together is effective, rather than using them alone. It was confirmed (Patent Document 1).

更に、天然抗酸化性成分の抗酸化活性を詳しく調べると、アミノ酸、ペプチドからなる抗酸化成分は、アンセリンやカルノシンと同様に、ClO・に対して、また、V.Eと同様に主として植物に由来しフェノール基を有する疎水性のカロテノイド類、ポリフェノール類、カフェ酸類縁体などはOH・に対して、強い抗酸化活性を有することが判明した。   Furthermore, when the antioxidant activity of the natural antioxidant component is examined in detail, the antioxidant component consisting of amino acids and peptides is similar to Anserine and Carnosine against ClO. As with E, hydrophobic carotenoids, polyphenols, caffeic acid analogues, etc., which are derived mainly from plants and have phenol groups, have been found to have strong antioxidant activity against OH.

これまで、抗酸化剤を各種疾病、特に生活習慣病を予防するために各種抗酸化剤が試験されてきた。たとえばV.C、V.E、β−カロチン、カテキンなどのポリフェノール類などである。しかし、これら抗酸化剤を単剤、或いは組み合わせ使用による疾病予防効果を調べた試験成績を見ると、たとえばガンなどの疾病予防について必ずしも有効であったという知見は多くない。逆に臨床的効果がないという知見も多くあり(非特許文献1)、期待されているほど抗酸化剤が疾病や老化の予防に効果を上げていなかったのである。   Until now, various antioxidants have been tested to prevent various diseases, particularly lifestyle-related diseases. For example V. C, V.D. And polyphenols such as E, β-carotene and catechin. However, looking at the test results of examining the disease prevention effect of using these antioxidants alone or in combination, there are not many findings that they were necessarily effective in preventing diseases such as cancer. Conversely, there are many findings that there is no clinical effect (Non-patent Document 1), and antioxidants have not been effective in preventing diseases and aging as expected.

この原因には、次の点が考えられる。まず生体内で発生する活性酸素は多種類のものがあり、単一の抗酸化剤でそれらの害作用を消去することが困難なこと、更に抗酸化剤の組み合わせにおいても、抗酸化活性が類似する成分同士の組み合わせ、たとえばV.Eとカロテノイド類やポリフェノール類の組み合わせなどであり、V.CとV.E、或いはV.Cとポリフェノール類の組み合わせでも性質の異なる3種の活性酸素を抑える配合ではなかったことなどである。   The following points can be considered as the cause. First, there are many types of active oxygen generated in the body, and it is difficult to eliminate their harmful effects with a single antioxidant, and the antioxidant activity is similar even in the combination of antioxidants Combinations of the components to be treated, such as V. A combination of E and carotenoids or polyphenols; C and V. E or V. For example, the combination of C and polyphenols was not a combination of suppressing three types of active oxygen having different properties.

更に植物由来の抗酸化剤、特にポリフェノール類の中には抗酸化作用だけでなく人間の遺伝子DNAを傷害する作用も知られており、時には発ガンや変異を促進する作用も報告されている(非特許文献2、3)。   Furthermore, plant-derived antioxidants, especially polyphenols, are known not only to have antioxidant effects but also to damage human genetic DNA, and sometimes have been reported to promote carcinogenesis and mutation ( Non-patent documents 2, 3).

特開2004−231902号公報JP 2004-231902 A J.Kaikkonenら、Free Radicals Research、33巻、329−340、2000年J. et al. Kaikkonen et al., Free Radicals Research, 33, 329-340, 2000 C.A.Austin,ら、Biochemistry Journal、282巻、883〜889頁、1992年C. A. Austin, et al., Biochemistry Journal, 282, 883-889, 1992. R.Sanyalら、Mutagenesis、12巻、297〜303頁、1997年R. Sanyal et al., Mutageness, 12, 297-303, 1997

このような状況の中で、本発明者らは、上記従来技術に鑑みて、多様な活性酸素種に対して有効に抗酸化能を発揮できる抗酸化組成物を開発することを目標として鋭意研究を重ねた結果、次亜塩素酸系活性酸素消去剤として、動物エキスから得られるヒスチジン含有ジペプチド混合体100m当たり、過酸化亜硝酸系活性酸素消去剤としてビタミンC(L−アスコルビン酸又はL−アスコルビン酸塩)を20mg以上、そして、水酸化ラジカル系活性酸素消去剤としてコエンザイムQ10などのユビキノン類を4mg以上の割合に配合した抗酸化組成物を開発することに成功し、本発明を完成するに至った。 Under such circumstances, the present inventors have found that in view of the above prior art, the goal of developing effective antioxidative set Narubutsu capable of exhibiting antioxidant properties for a variety of reactive oxygen species As a result of extensive research, vitamin C (L-ascorbic acid or L) was used as a peroxynitrite-based active oxygen scavenger per 100 m of a histidine-containing dipeptide mixture obtained from animal extracts as a hypochlorous acid-based active oxygen scavenger. - ascorbate) was 20mg or greater, and have succeeded in developing an anti-oxidative pairs Narubutsu the ubiquinones were formulated into the proportion of more than 4mg such coenzyme Q10 as hydroxyl radicals based active oxygen eliminator, the present invention It came to complete.

本発明は、多様な活性酸素種に対して有効に抗酸化能を発揮できる抗酸化組成物を提供することを目的とするものである。   An object of this invention is to provide the antioxidant composition which can exhibit antioxidant ability effectively with respect to various reactive oxygen species.

上記課題を解決するための本発明は、以下の技術的手段から構成される。
(1)生体内で産生される活性酸素種に対して、次亜塩素酸系活性酸素消去剤として、動物エキスから得られるヒスチジン含有ジペプチド混合体100mg当たり、過酸化亜硝酸系活性酸素消去剤として、ビタミンC(L−アスコルビン酸又はL−アスコルビン酸塩)を20mg以上、そして、水酸化ラジカル系活性酸素消去剤として、コエンザイムQ10を含むユビキノン類を4mg以上10mg以下の割合に配合したことを特徴とする、次亜塩素酸ラジカル、水酸化ラジカル及び過酸化亜硝酸ラジカルの3種を抑制する作用を有する抗酸化組成物。
(2)上記の次亜塩素酸系活性酸素消去剤が、家禽、牛、豚、又は回遊性魚類の筋肉を熱水抽出して得られる動物エキス中に含まれるヒスチジン含有ジペプチドのアンセリンとカルノシンの混合体である前記(1)に記載の抗酸化組成物。
The present invention for solving the above-described problems comprises the following technical means.
(1) As a hypochlorite-based active oxygen scavenger for reactive oxygen species produced in vivo, as a peroxynitrite-based active oxygen scavenger per 100 mg of a histidine-containing dipeptide mixture obtained from animal extracts Vitamin C (L-ascorbic acid or L-ascorbate) is 20 mg or more and, as a hydroxyl radical active oxygen scavenger, ubiquinone containing coenzyme Q10 is blended in a ratio of 4 mg to 10 mg. to a radical hypochlorite, antioxidative set Narubutsu having an action to suppress the three hydroxyl radicals and peroxynitrite radicals.
(2) The above-mentioned hypochlorous acid-based active oxygen scavenger is an anserine and carnosine histidine-containing dipeptide contained in an animal extract obtained by hot water extraction of poultry, cow, pig, or migratory fish muscle. antioxidative sets composition as claimed in a mixture of the (1).

次に、本発明について更に詳細に説明する。
本発明では、上記3種の活性酸素を抑える配合とするために、広い範囲の活性酸素種に対応できる抗酸化剤の配合であることと、エネルギー代謝の過程で発生するOH・に十分に対応できるより安全性に優れた素材を選択することが重要である。上記のように、動物原料から得られる抗酸化性ペプチドのアンセリンとカルノシンや硫黄含有アミノ酸類はClO・に対して強い抗酸化作用を持ち、水溶性ビタミンであるV.CはONOO・に対して強い抗酸化作用を持つ。そして、本発明者らは、OH・に対して強い抗酸化作用を持つ成分として既に明らかにしたV.E、カロテノイド類、ポリフェノール類、カフェ酸類縁体以外に、生物の細胞に存在するユビキノン類があることを発見した。
Next, the present invention will be described in more detail.
In the present invention, in order to make the above-mentioned three types of active oxygen suppressive, it is a mixture of antioxidants capable of dealing with a wide range of active oxygen species, and sufficiently copes with OH · generated in the process of energy metabolism. It is important to select materials that are safer than possible. As described above, the antioxidant peptides anserine, carnosine and sulfur-containing amino acids obtained from animal raw materials have a strong antioxidant action against ClO. C has a strong antioxidant action against ONOO. And the present inventors have already clarified as a component having a strong antioxidant action against OH. In addition to E, carotenoids, polyphenols, and caffeic acid analogs, it was discovered that there are ubiquinones present in living cells.

ユビキノンの代表的な成分であるコエンザイムQ10(以下CoQ10と略記)はエネルギー代謝を行うミトコンドリアに主として存在し、重要な電子伝達系成分であるが、これが強い抗酸化作用を持っていることが知られている。人間にとってCoQ10は植物に由来するものではなく、アンセリンやカルノシンと同様に人間の体内に存在する成分であり、植物由来の抗酸化剤のようなDNA傷害作用を持っていない。しかもミトコンドリアではエネルギー代謝の過程で夥しい活性酸素が生産されており、それらはO からHを経由してOH・を発生するが、ミトコンドリアに存在するCoQ10の抗酸化作用を調べると、これはV.Eより強く、カテキンやカフェ酸類縁体と同等の強いOH・抗酸化作用を持っていた。ただし、CoQ10も植物由来の抗酸化剤と同様に生理的に存在できる濃度ではClO・やONOO・に対する抗酸化作用は示さなかった。 Coenzyme Q10 (hereinafter abbreviated as CoQ10), which is a typical component of ubiquinone, is mainly present in mitochondria that perform energy metabolism and is an important electron transport system component, but it is known to have a strong antioxidant effect. ing. For humans, CoQ10 is not derived from plants, but is a component that exists in the human body like anserine and carnosine, and does not have a DNA-damaging effect like plant-derived antioxidants. Moreover, in the mitochondria, heavy active oxygen is produced in the process of energy metabolism, and they generate OH · from O 2 via H 2 O 2 , but when examining the antioxidant effect of CoQ10 present in mitochondria This is V. It was stronger than E and had strong OH / antioxidant action equivalent to catechin and caffeic acid analogues. However, CoQ10 did not exhibit an antioxidant action against ClO. Or ONOO. At concentrations that can be physiologically present as well as plant-derived antioxidants.

本発明者らは、安全性に優れたOH・消去能が強い抗酸化剤の素材について探索したところ、上記したように、ユビキノン類の一つであるCoQ10を見出し、そして、ClO・消去能の強いアンセリン−カルノシン混合体とV.CとCoQ10を所定の配合割合で配合することにより、3種の活性酸素に相乗的な理想的な抗酸化活性を持つ抗酸化組成物の調製が可能であることを見出した。 As a result of searching for a material for an antioxidant with excellent safety and strong OH / erasing ability, the present inventors have found CoQ10, which is one of ubiquinones, and have a ClO / erasing ability. Strong anserine-carnosine mixture and V. By blending C and CoQ10 at a predetermined mixing ratio, and we found that it is possible to synergistic ideal antioxidant activity Preparation of Kosan of sets Narubutsu with the three active oxygen.

本発明では、次亜塩素酸系活性酸素消去剤として、動物エキスから得られるヒスチジン含有ジペプチド混合体100mg当たり、過酸化亜硝酸系活性酸素消去剤としてビタミンC(L−アスコルビン酸又はL−アスコルビン酸塩)を20mg以上、そして、水酸化ラジカル系活性酸素消去剤として、コエンザイムQ10などのユビキノン類を4mg以上の割合に配合する。このように、本発明は、上記成分を所定の配合割合で配合することが重要である。これらの範囲以外では、本発明の3種の活性酸素に対する特異的な抗酸化性作用は得られない。 In the present invention, vitamin C (L-ascorbic acid or L-ascorbine is used as a peroxynitrite-based active oxygen scavenger per 100 mg of a histidine-containing dipeptide mixture obtained from animal extracts as a hypochlorous acid-based active oxygen scavenger. Acid salt) is added in an amount of 20 mg or more, and ubiquinones such as coenzyme Q10 are blended in a proportion of 4 mg or more as a hydroxyl radical active oxygen scavenger. Thus, in the present invention, it is important to blend the above components at a predetermined blending ratio. Outside these ranges, the specific antioxidant action on the three active oxygens of the present invention cannot be obtained.

この場合、上記の次亜塩素酸系活性酸素消去剤としては、好適には、例えば、家禽、牛、豚、又は回遊性魚類の筋肉を熱水抽出して得られる動物エキス中に含まれるヒスチジン含有ジペプチドのアンセリンとカルノシンの混合体が例示されるが、これらと同効のものであれば同様に使用することができる。 In this case, as the above hypochlorous acid-based active oxygen scavenger, preferably, for example, histidine contained in an animal extract obtained by hot water extraction of muscle of poultry, cattle, pigs, or migratory fish mixture of dipeptides containing anserine and carnosine are illustrated, but can be similarly used as long as the these same effect.

これまで、2〜3成分の抗酸化組成物で、3種の活性酸素に対して有効な組成物は、これまで報告された例はない。このことからも、本発明の抗酸化組成物は、従来製品にない優れた著効を奏するものであることが明白である。 So far, anti-oxidative pairs formed of 2-3 components, effective compositions against three active oxygen, and the example is not reported. This also antioxidative sets composition as the present invention, it is apparent that those achieving the no good remarkable effect in conventional products.

これまで、単一の抗酸化剤を含有する食品が生活習慣病予防や老化予防の目的のために広く利用されてきたが、臨床試験では必ずしも十分な効果を上げて来なかった。この原因は、疾病や老化を促進する生体内の活性酸素は単一のものではなく、各種の活性酸素種が存在すること、一方、抗酸化剤は多種多様な活性酸素種を全て抑制するものは極めて稀であり、抗酸化作用を強く発揮できるものとできない活性酸素種があるためと考えられる。本発明者らは、既に生体内で発生する活性酸素種を塩素系、水酸化ラジカル系、窒素酸化物系に3大別して各種抗酸化剤の作用を試験すると、動物エキスに存在するヒスチジン含有ペプチドや硫黄含有アミノ酸又はペプチド類は塩素系活性酸素に対して、植物に由来し脂溶性を示すポリフェノール類、カロテノイド類、カフェ酸類縁体などは水酸化ラジカルに対して、更に窒素酸化物系に対してはビタミンCが強い抗酸化作用を示すことを明らかにして来た。   Until now, foods containing a single antioxidant have been widely used for the purpose of preventing lifestyle-related diseases and aging, but have not always been sufficiently effective in clinical trials. This is because the active oxygen in the living body that promotes illness and aging is not a single thing, but there are various reactive oxygen species, while antioxidants suppress all of the various active oxygen species. Is considered to be due to the presence of reactive oxygen species that are extremely rare and unable to exert strong antioxidant effects. The inventors of the present invention have examined the action of various antioxidants by classifying the active oxygen species already generated in the living body into chlorine, hydroxyl radicals, and nitrogen oxides, and found that histidine-containing peptides present in animal extracts. And sulfur-containing amino acids or peptides against chlorinated active oxygen, polyphenols, carotenoids, caffeic acid analogues, etc. that are derived from plants and that are fat-soluble against hydroxylated radicals, and further against nitrogen oxides It has been revealed that vitamin C exhibits a strong antioxidant effect.

そして、これらを適切に配合することによって理想的な抗酸化作用を持つ抗酸化組成物を調製することが可能となった。本発明は、水酸化ラジカルに対して強い抗酸化作用を持ち、しかし、ポリフェノール類のようにDNA傷害作用や変異原性を持たない抗酸化成分であるユビキノン類のCoQ10を水酸化ラジカル消去剤として他の成分と配合することにより、より安全性が高く、かつ完全な抗酸化作用を持つ抗酸化組成物の調製可能とするものである。本発明は、長期間摂取してもより安全性が高く、従って、生体内で発生する各種活性酸素による疾病の発生や老化を抑制する効果が期待できる抗化組成物を提供することを可能とするものである。 And it became possible to prepare the antioxidant composition which has an ideal antioxidant effect by mix | blending these appropriately. The present invention has a strong antioxidant action against hydroxyl radicals, but CoQ10 of ubiquinones, which is an antioxidant component having no DNA damaging action or mutagenicity like polyphenols, as a hydroxyl radical scavenger. by blending with other components, it is to allow for the preparation of Kosan of sets Narubutsu with the safety is high, and complete antioxidant. This onset Ming, more safety even when ingested long time is high, thus provides the antioxidative sets Narubutsu effect of suppressing aging and diseases caused by various active oxygen generated in vivo that can be expected It is possible to do that.

次に、本発明を試験例に基づいて更に詳細に説明する。
(1)3種の活性酸素による卵白アルブミン(Ovalbumin、以下Ovaと略記)分解作用に対する各種抗酸化剤の阻止作用
生体内で産生される典型的活性酸素としてClO・、OH・及びONOO・の3種を調製した。ClO・は亜塩素酸ナトリウムをpH6.5の蒸留水に希釈する方法で、OH・はFenton法(B.Halliwellら、Analytical Biochemistry 165巻、215〜219頁、1987年)を一部改変して、また、ONOO・はquenching flow reactor法(R.Radiら、Journal of Biological Chemistry266巻、4244〜4250頁、1991年)を改変して調製した。
Next, the present invention will be described in more detail based on test examples.
(1) Inhibiting action of various antioxidants against ovalbumin (Ovalbumin, hereinafter abbreviated as Ova) degradation action by three kinds of active oxygen 3 of ClO., OH. And ONOO. As typical active oxygen produced in vivo Seeds were prepared. In the method ClO · is to dilute the sodium hypochlorite of distilled water pH 6.5, OH · the Fenton method (B.Halliwell et al, Analytical Biochemistry 165, pp. 215-219, 1987) was partially modified ONOO. Was prepared by modifying the quenching flow reactor method (R. Radi et al., Journal of Biological Chemistry 266, 4244-4250, 1991).

次に、Ovaを2.5mg/mLになるように緩衝化生理食塩水、pH7.4に溶解し、蛋白質溶液に対して10:1の容量比で各濃度の抗酸化剤を添加して室温で30分間静置させ、次いで、同じく蛋白質溶液に対して10:1の容積比で各濃度の活性酸素を添加して、ClO・酸化は37℃、30分間、OH・酸化は37℃、60分間、ONOO・酸化は37℃、120分間反応させた。反応後、各試料溶液をドデシル硫酸ナトリウムーポリアクリルアミドゲル電気泳動法(SDS−PAGE)で泳動した後、クマシーブリリアントブルーR250染色液で染色したゲルをデンシトメーターにかけてOvaの分解阻止率を計算した。また、正確な分解阻止率は反応試料液を直接TSKG−3,000SWカラムのGPC−HPLCにかけて、蛋白分解阻止活性を次の式で算出した。   Next, Ova was dissolved in buffered saline, pH 7.4 to 2.5 mg / mL, and an antioxidant of each concentration was added at a volume ratio of 10: 1 to the protein solution, and room temperature was added. The active oxygen of each concentration was added at a volume ratio of 10: 1 to the protein solution, and the ClO / oxidation was 37 ° C. for 30 minutes, the OH / oxidation was 37 ° C., 60 The ONO / oxidation was allowed to react at 37 ° C. for 120 minutes. After the reaction, each sample solution was electrophoresed with sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and the gel stained with Coomassie Brilliant Blue R250 staining solution was subjected to densitometer to calculate the Ova decomposition inhibition rate. . In addition, the accurate decomposition inhibition rate was calculated by applying the reaction sample solution directly to GPC-HPLC of a TSKG-3,000SW column and calculating the proteolysis inhibition activity by the following formula.

分解阻止率(%)=抗酸化剤添加時の活性酸素分解蛋白質のピーク面積/未分解対照蛋白質のピーク面積×100   Decomposition inhibition rate (%) = peak area of active oxygen degrading protein when antioxidant is added / peak area of undegraded control protein × 100

3種の活性酸素によるOva酸化分解に対する各種抗酸化剤及び3種配合剤のタンパク質分解阻止作用は図1に示す通りである。ClOラジカル(ClO・)に対しては、チキンエキス由来精製アンセリン−カルノシン混合体や硫黄含有アミノ酸又はペプチド類が最も強く、次いで、ビタミンC(V.C)であったが、CoQ10は、タンパク質分解阻止作用を全く示さなかった。OHラジカル(OH・)に対しては、50μM濃度のCoQ10が最も強いタンパク質分解阻止作用を示し、アンセリン−カルノシンとV.Cは、抗酸化作用をほとんど示さなかった。   The proteolysis-inhibiting action of various antioxidants and the three compounding agents against Ova oxidative degradation by three active oxygens is as shown in FIG. For the ClO radical (ClO.), The purified anserine-carnosine mixture and sulfur-containing amino acids or peptides derived from chicken extract were the strongest, followed by vitamin C (VC), but CoQ10 was proteolytic It did not show any blocking action. For OH radicals (OH.), CoQ10 at a concentration of 50 μM exhibits the strongest proteolytic inhibitory action, and anserine-carnosine and V. C showed little antioxidant effect.

一方、ONOOラジカル(ONOO・)に対しては、V.Cがタンパク質分解作用を完全に阻止したが、チキンエキス由来のアンセリン−カルノシン、硫黄含有アミノ酸−ペプチド及びCoQ10のタンパク質分解阻止作用はいずれも弱いものであった。また、チキンエキス由来アンセリン−カルノシン混合体5mM、CoQ10を50μM、及びV.Cを5mM濃度に配合した3種配合抗酸化組成物の場合は、図1に示す通り、3種の活性酸素によるタンパク質分解作用をほぼ完全に阻止する結果であった。これらのタンパク質分解阻止活性を要約すると表1の「各種活性酸素のタンパク質分解に対する各抗酸化剤の阻止作用(%)」の通りである。   On the other hand, for the ONOO radical (ONOO.), V.I. Although C completely prevented the proteolytic action, the proteolytic inhibitory action of chicken extract-derived anserine-carnosine, sulfur-containing amino acid-peptide and CoQ10 were all weak. Chicken extract-derived anserine-carnosine mixture 5 mM, CoQ10 50 μM, and V.I. In the case of the three mixed antioxidant compositions containing C at a concentration of 5 mM, as shown in FIG. 1, the result was that the proteolytic action by the three active oxygens was almost completely prevented. These proteolytic inhibitory activities are summarized in Table 1 as “inhibitory action (%) of each antioxidant against proteolysis of various active oxygens”.

(2)活性酸素によるヒト赤血球のマイクロチャンネル通過能障害と抗酸剤の防止効果
微細血管モデルであるマイクロチャンネル(MCと略記)は、血液レオロジー、すなわち血液の微細血管循環能を測定する装置である。血液レオロジーに及ぼす要因として、食事、酸化ストレスなどが挙げられている。本発明では、生体内で生成される3種の活性酸素の人赤血球のMC通過能に及ぼす影響を試験し、各種抗酸化剤と3種配合剤の活性酸素によるヒト赤血球流動性障害作用の防止効果について試験した。
(2) Impaired microchannel passage ability of human erythrocytes due to active oxygen and anti-acid preventive effect Microchannel (abbreviated as MC) is a device that measures blood rheology, that is, microvascular circulation ability of blood. is there. Factors affecting blood rheology include diet and oxidative stress. In the present invention, the effects of three types of active oxygen produced in vivo on the ability of human erythrocytes to pass through MC are tested, and prevention of human erythrocyte fluidity disorder effects by the active oxygen of various antioxidants and three kinds of combination agents. The effect was tested.

試験方法は、健康人志願者血液をFicoll−Paque遠心法(ファルマシァ社製)で赤血球画分を採取し、MCFAN KH−3A(チャンネル幅7μm、MC研究所)により各種活性酸素処理した場合の赤血球(最終ヘマトクリット濃度10%)のMC通過時間を測定した。その結果、ClO・、OH・及びONOO・の3種の活性酸素によりヒト赤血球はいずれも通過障害を起こしたが、ClO・ではチキンエキス由来アンセリン−カルノシン混合体が、OH・ではCoQ10が、そして、ONOO・ではV.Cが最もMC通過能の低下を防止する結果であった。抗酸化剤3種配合の場合は、いずれの場合も活性酸素によるMC通過能の低下は認められなかった(図2)。   In the test method, red blood cells were collected from blood of healthy volunteers using Ficoll-Paque centrifugation (Pharmacia) and treated with various active oxygens using MCFAN KH-3A (channel width: 7 μm, MC Laboratory). The MC transit time (final hematocrit concentration 10%) was measured. As a result, all three types of active oxygen, ClO., OH. And ONOO., Caused human erythrocytes to pass through. In ClO., Chicken extract-derived anserine-carnosine mixture, in OH., CoQ10, and , ONOO. C was the result which prevented the fall of MC passage ability most. In the case of the combination of the three antioxidants, no decrease in MC passage ability due to active oxygen was observed in any case (FIG. 2).

(3)健康人での血液レオロジー改善効果
健常人男子(58歳、35歳、29歳)を対象に、1瓶中にチキンエキス由来アンセリン−カルノシン混合体400mg、ビタミンC300mg及びCoQ10 20mgを含有する果汁飲料50mLを毎日1本、10日間飲用し、飲用前後の血液流動性改善効果について上記のMCFAN KH−3Aを用いてMC通過時間を測定することにより試験した。その結果、3種抗酸化剤配合飲料を飲用する前の平均MC通過時間は55.1秒であったが、飲用後の平均MC通過時間は46.6秒まで改善された(図3)。
(3) Blood rheology improvement effect in healthy persons Targeting healthy males (58 years old, 35 years old, 29 years old), one bottle contains chicken extract-derived anserine-carnosine mixture 400 mg, vitamin C 300 mg and CoQ10 20 mg 50 mL of fruit juice was drunk daily for 10 days, and the blood fluidity improvement effect before and after drinking was tested by measuring the MC passage time using the above MCFAN KH-3A. As a result, the average MC passage time before drinking the three kinds of antioxidant-containing beverages was 55.1 seconds, but the average MC passage time after drinking was improved to 46.6 seconds (FIG. 3).

本発明により、以下のような効果が奏される。
(1)本発明は、多様な活性酸素種に対して有効に抗酸化能を発揮できる抗酸化組成物を提供することができる。
(2)生体内で産生される次亜塩素酸ラジカル、水酸化ラジカル及び過酸化亜硝酸ラジカルの3種の活性酸素種に対して相乗的な抗酸化作用を持つ特定の成分を組み合わせて成る抗酸化組成物を提供することができる。
(3)本発明は、生活習慣病の予防や老化防止に有効な新規抗酸化組成物を提供することができる。
The following effects are exhibited by the present invention.
(1) The present invention can provide an anti-oxidative pairs Narubutsu can effectively exhibit antioxidant properties for a variety of reactive oxygen species.
(2) An anti-antigen comprising a combination of specific components having a synergistic antioxidant action on three active oxygen species, hypochlorous acid radical, hydroxyl radical and peroxynitrite radical produced in vivo. it is possible to provide an acid of sets Narubutsu.
(3) The present invention can provide an effective new anti-oxidative pairs Narubutsu the prevention and anti-aging lifestyle diseases.

次に、実施例に基づいて本発明を具体的に説明するが、本発明は、以下の実施例によって何ら限定されるものではない。   EXAMPLES Next, although this invention is demonstrated concretely based on an Example, this invention is not limited at all by the following Examples.

丸鶏400kgから熱水抽出して得られたチキンエキス1,200Lを濃縮して電気伝導度25mS/cmになるように塩濃度を調整し、これをあらかじめ0.05Mクエン酸緩衝液に平衡化したDowex50−X8陽イオン交換体を充填したカラムに通液してチキンエキス中のアンセリンとカルノシンを該イオン交換体に吸着せしめ、イオン交換体を同緩衝液で十分に洗浄した後、希アルカリ溶液でアンセリンとカルノシンを該イオン交換カラムより溶出させて回収した。陽イオン交換体より溶出したアンセリンとカルノシンの混合体を減圧下に濃縮した後、塩酸でpHを中性に調整し、活性炭を2%(W/W)添加して脱色し、ろ紙によるろ過で活性炭を除去した。ここに得られた精製アンセリン−カルノシンの純度は固形物当たり約78%であった。   Concentrate 1,200 L of chicken extract obtained by hot water extraction from 400 kg of whole chicken, adjust the salt concentration so that the electric conductivity is 25 mS / cm, and equilibrate it to 0.05 M citrate buffer beforehand. After passing through a column packed with the Dowex 50-X8 cation exchanger, the anserine and carnosine in the chicken extract were adsorbed to the ion exchanger, and the ion exchanger was thoroughly washed with the same buffer, and then diluted with alkaline solution. The anserine and carnosine were eluted from the ion exchange column and recovered. Concentrate the mixture of anserine and carnosine eluted from the cation exchanger under reduced pressure, adjust the pH to neutral with hydrochloric acid, add 2% (W / W) of activated carbon, decolorize, and filter with filter paper. Activated carbon was removed. The purity of the purified anserine-carnosine obtained here was about 78% per solid.

該チキンエキス由来アンセリン−カルノシン混合体をマンゴ果汁(60%)50mL中に400mg、そしてV.Cを300mg(和光純薬製)、CoQ10水溶性化エマルジョン(横浜油脂製)0.2g(CoQ10として20mg)を添加し、3種の抗酸化成分含有の果汁飲料を調製した。本飲料は試験例(3)で示したように健康人の血液流動性を改善する効果が観察された。   400 mg of the chicken extract-derived anserine-carnosine mixture in 50 mL of mango juice (60%); 300 mg of C (manufactured by Wako Pure Chemical Industries) and 0.2 g of CoQ10 water-solubilized emulsion (manufactured by Yokohama Oil and Fats) (20 mg as CoQ10) were added to prepare a juice drink containing three antioxidant components. As shown in Test Example (3), the effect of improving the blood fluidity of healthy people was observed in this beverage.

丸鶏を熱水抽出して得られたチキンエキスを濃縮した後、固形物当たりのアンセリン−カルノシン含量が10%になるように調整して噴霧乾燥し、チキンエキス粉末を調製した。該チキンエキス粉末2.0g当たりV.C(和光純薬)150mg、CoQ10粉末(日清ファルマ製)200mg(CoQ10として10mg)を添加し、更にコーン粉末8g、玉ねぎパウダー1g、調味料1gを加え、即席用コーンスープ粉末を調製した。該コーンスープ粉末12.6gを80℃の湯100mLに溶解することにより簡便に抗酸化性強化コーンポタージュスープとして食卓に供すことが可能であった。また、該コーンスープ液について上記の3種の活性酸素によるin vitroでのタンパク質分解作用に対する防止作用を試験したところ、いずれの活性酸素によるタンパク質分解作用も完全に抑制する結果であった。   After concentrating the chicken extract obtained by extracting the whole chicken with hot water, the anserine-carnosine content per solid was adjusted to 10% and spray-dried to prepare a chicken extract powder. V. per 2.0 g of the chicken extract powder. 150 mg of C (Wako Pure Chemical Industries), 200 mg of CoQ10 powder (manufactured by Nisshin Pharma) (10 mg as CoQ10) were added, and 8 g of corn powder, 1 g of onion powder, and 1 g of seasoning were further added to prepare instant corn soup powder. By dissolving 12.6 g of the corn soup powder in 100 mL of hot water at 80 ° C., it was possible to easily provide the table as an antioxidant enhanced corn potage soup. Further, when the corn soup solution was tested for its in vitro proteolytic action by the above three active oxygens, the proteolytic action by any active oxygen was completely suppressed.

以上詳述した通り、本発明は、抗酸化組成物に係るものであり、本発明により、広い範囲の活性酸素種に対して有効に作用する抗酸化組成物を提供することができる。これまで単一の抗酸化剤を含有する食品が生活習慣病予防や老化予防の目的のために広く利用されてきた。例えば、動脈硬化や高血圧、ガン、糖尿病や糖尿病に併発する各種疾患などである。しかしながら、これまで行われて来た抗酸化剤の生活習慣病や老化予防の臨床試験では、必ずしも十分な効果を上げてこなかった現実がある。この原因はいろいろ考えられるが、第一に、試験管内や動物に強制投与して得られる臨床的効果が、実際に人間に経口摂取される場合には、腸管吸収性の問題や生体内分布の問題があったことがあげられる。特に、植物由来のポリフェノール類が該当する。第二には、老化や生活習慣病の原因となる生体内の活性酸素は、単一のものではなく、人間の生活習慣や生理的条件によってさまざまな種類のものが発生していることである。従来、抗酸化剤の活性の強度は生体内で発生する活性酸素と関連性の乏しい活性酸素を対象に評価され、その基準で強さの順位が規定されてきた。しかし、本発明の試験で確認されたように、生理的に調節可能な濃度での各種抗酸化剤の作用にはそれぞれ活性酸素種に対する特異性が存在し、従来、抗酸化活性が弱いと評価されたものでも特定の活性酸素に対して強い抗酸化作用を発揮すること、逆に、強い抗酸化剤と評価されてきたものでも作用が弱い活性酸素が存在することが明らかとなった。これらのことから、単一の抗酸化剤を主成分とする食品では生体内で発生するさまざまな活性酸素によって発症する各種疾病を十分に防止できなかったと考えられる。 As described in detail above, the present invention according to the antioxidative group formed product, the present invention can provide an antioxidant composition acting effectively against a wide range of reactive oxygen species. Until now, foods containing a single antioxidant have been widely used for the purpose of preventing lifestyle-related diseases and aging. For example, arteriosclerosis, hypertension, cancer, various diseases associated with diabetes and diabetes. However, in the clinical trials for preventing lifestyle-related diseases and aging prevention of antioxidants that have been conducted so far, there is a reality that has not necessarily been sufficiently effective. There are many possible causes for this, but first, if the clinical effects obtained by inhalation in vitro or in animals are actually taken orally by humans, problems with intestinal absorption and biodistribution may occur. There was a problem. In particular, plant-derived polyphenols are applicable. Second, reactive oxygen in the living body that causes aging and lifestyle-related diseases is not a single one, but various types of oxygen are generated depending on human lifestyle and physiological conditions. . Conventionally, the strength of the activity of an antioxidant has been evaluated for active oxygen that is poorly related to the active oxygen generated in the living body, and the order of strength has been defined by that standard. However, as confirmed in the test of the present invention, the action of various antioxidants at physiologically adjustable concentrations has specificity for reactive oxygen species, and it has been conventionally evaluated that the antioxidant activity is weak. It has been clarified that even those that have been demonstrated to exhibit a strong antioxidant action against specific active oxygen, and conversely, even those that have been evaluated as strong antioxidants have active oxygen that has a weak action. From these facts, it is considered that foods mainly composed of a single antioxidant could not sufficiently prevent various diseases caused by various active oxygens generated in the living body.

本発明では、生体内で発生する活性酸素種を3大別し、酸素ガスから発生するOH・系、白血球が生成する塩素系と窒素酸化物系の活性酸素に対する抗酸化剤の特定を行った。その結果、ヒスチジン含有ジペプチド混合体が塩素系活性酸素に対して、コエンザイムQ10などのユビキノン類はOH・系に対して、そして、ビタミンCなどが窒素酸化物系の活性酸素に対して強い抗酸化活性を示すことを明らかにした。これらの知見から、広い範囲の活性酸素種に対して有効に作用する抗酸化剤の配合が重要であり、実際に抗酸化剤を配合することによって酸化障害によって起こる生体内での最終糖化産物の生成が顕著に抑制する効果が認められ、このことから、老化や生活習慣病の発生抑制に従来より更に効果的な抗酸化組成物の提供が可能となった。また、これらの抗酸化成分を含有する天然素材を配合することによっても、より効果的な抗酸化組成物の製造が可能である。 In the present invention, the active oxygen species generated in the living body are classified into three categories, and the antioxidants for OH · system generated from oxygen gas, chlorine-based and nitrogen oxide-based active oxygen generated by white blood cells were specified. . As a result, the histidine-containing dipeptide mixture is strong against chlorinated active oxygen, ubiquinones such as coenzyme Q10 are strong against OH, and vitamin C is strong against nitrogenous active oxygen. It was clarified to show activity. From these findings, it is important to formulate antioxidants that act effectively on a wide range of reactive oxygen species, and the final glycation product in vivo caused by oxidative damage caused by the actual incorporation of antioxidants is important. The effect which suppresses generation | occurrence | production remarkably was recognized, and from this, it became possible to provide the antioxidant composition more effective than before in the suppression of the occurrence of aging and lifestyle-related diseases. Also, a more effective antioxidant composition can be produced by blending natural materials containing these antioxidant components.

各種抗酸化剤の活性酸素による卵白アルブミン分解作用の阻止効果を示す。Aは10mMのClOラジカル、Bは10mMのOHラジカル、CはONOOラジカルの酸化分解である。各パネルのRは未処理卵白アルブミン、Cは酸化分解卵白アルブミン対照、1はチキンエキス由来精製アンセリン−カルノシン混合体5mM、2はビタミンC 5mM、3はコエンザイムQ10 50μM、4はこれら3種の抗酸化剤の配合物である。The inhibitory effect of ovalbumin degradation action by active oxygen of various antioxidants is shown. A is 10 mM ClO radical, B is 10 mM OH radical, and C is oxidative decomposition of ONOO radical. In each panel, R is untreated ovalbumin, C is oxidatively decomposed ovalbumin control, 1 is a purified anserine-carnosine mixture derived from chicken extract 5 mM, 2 is vitamin C 5 mM, 3 is coenzyme Q10 50 μM, It is a blend of oxidizing agents. 各種活性酸素によるヒト赤血球のマイクロチャンネル(MC)通過能低下作用に対する各種抗酸化成分とその配合剤による防止効果を示す。パネルAは10mMのClOラジカル、パネルBは10mMのOHラジカル、パネルCは5mMのONOOラジカルによる酸化分解である。各パネルは、左から順に、抗酸化剤非添加対照、チキンエキス由来精製アンセリン−カルノシン混合体添加、ビタミンC添加、コエンザイムQ10添加、3種配合添加、である。The prevention effect by the various antioxidant component and its compounding agent with respect to the microchannel (MC) passage ability decreasing effect of the human erythrocyte by various active oxygen is shown. Panel A is 10 mM ClO radical, Panel B is 10 mM OH radical, and Panel C is oxidative decomposition by 5 mM ONOO radical. Each panel is, in order from the left, an antioxidant-free control, a chicken extract-derived purified anserine-carnosine mixture, vitamin C, coenzyme Q10, and three types. 健常人の血液流動性改善作用を示す。It shows the blood fluidity improving effect of healthy people.

Claims (2)

生体内で産生される活性酸素種に対して、次亜塩素酸系活性酸素消去剤として、動物エキスから得られるヒスチジン含有ジペプチド混合体100mg当たり、過酸化亜硝酸系活性酸素消去剤として、ビタミンC(L−アスコルビン酸又はL−アスコルビン酸塩)を20mg以上、そして、水酸化ラジカル系活性酸素消去剤として、コエンザイムQ10を含むユビキノン類を4mg以上10mg以下の割合に配合したことを特徴とする、次亜塩素酸ラジカル、水酸化ラジカル及び過酸化亜硝酸ラジカルの3種を抑制する作用を有する抗酸化組成物。 Vitamin C as a peroxynitrite-based active oxygen scavenger per 100 mg of a histidine-containing dipeptide mixture obtained from animal extracts as a hypochlorite-based active oxygen scavenger for reactive oxygen species produced in vivo (L-ascorbic acid or L-ascorbate) is 20 mg or more, and, as a hydroxyl radical active oxygen scavenger, ubiquinones containing coenzyme Q10 are blended in a ratio of 4 mg to 10 mg, hypochlorite radical, anti-oxidation set Narubutsu having an action to suppress the three hydroxyl radicals and peroxynitrite radicals. 上記の次亜塩素酸系活性酸素消去剤が、家禽、牛、豚、又は回遊性魚類の筋肉を熱水抽出して得られる動物エキス中に含まれるヒスチジン含有ジペプチドのアンセリンとカルノシンの混合体である請求項1に記載の抗酸化組成物。 The hypochlorous acid-based active oxygen scavenger is a mixture of an anserine and carnosine, a histidine-containing dipeptide contained in an animal extract obtained by hot-water extraction of poultry, cow, pig, or migratory fish muscle. antioxidative sets composition as claimed in certain claim 1.
JP2005085028A 2004-04-30 2005-03-23 Antioxidant composition Active JP4971597B2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP2005085028A JP4971597B2 (en) 2005-03-23 2005-03-23 Antioxidant composition
TW094114124A TWI307267B (en) 2004-04-30 2005-05-02 Antioxidant constituents
US11/118,368 US7727961B2 (en) 2004-04-30 2005-05-02 Antioxidant constituents
US12/753,481 US20100240599A1 (en) 2004-04-30 2010-04-02 Antioxidant constituents

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005085028A JP4971597B2 (en) 2005-03-23 2005-03-23 Antioxidant composition

Publications (2)

Publication Number Publication Date
JP2006265161A JP2006265161A (en) 2006-10-05
JP4971597B2 true JP4971597B2 (en) 2012-07-11

Family

ID=37201497

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005085028A Active JP4971597B2 (en) 2004-04-30 2005-03-23 Antioxidant composition

Country Status (1)

Country Link
JP (1) JP4971597B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5142126B2 (en) * 2007-08-22 2013-02-13 東海物産株式会社 Method for producing antioxidant dipeptide
JP2010202574A (en) * 2009-03-03 2010-09-16 Hamamatsu Photonics Kk Production-enhancing agent for active oxygen species

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9722361D0 (en) * 1997-10-24 1997-12-17 Pharma Nord Uk Ltd Pharmaceutical formulation for treating liver disorders
TWI329513B (en) * 2001-10-12 2010-09-01 Kaneka Corp Use of reduced coenzyme q for lessening oxidative stress
JP4567945B2 (en) * 2003-01-17 2010-10-27 太陽化学株式会社 Ubidecarenone formulation
JP4833502B2 (en) * 2003-01-31 2011-12-07 東海物産株式会社 Antioxidant composition
JP2005060252A (en) * 2003-08-19 2005-03-10 Sanei Gen Ffi Inc Coenzyme q10 preparation

Also Published As

Publication number Publication date
JP2006265161A (en) 2006-10-05

Similar Documents

Publication Publication Date Title
Çetin et al. Cisplatin impairs antioxidant system and causes oxidation in rat kidney tissues: possible protective roles of natural antioxidant foods
JP5089025B2 (en) Antioxidant composition
CENGIZ et al. The effects of carbamazepine and valproic acid on the erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children
Ekambaram et al. Therapeutic efficacy of Tamarindus indica (L) to protect against fluoride-induced oxidative stress in the liver of female rats
Aslan et al. Royal jelly can diminish secondary neuronal damage after experimental spinal cord injury in rabbits
JP2015129112A (en) Catalase expression-inducing agents
JP4971597B2 (en) Antioxidant composition
US20100240599A1 (en) Antioxidant constituents
KR20180116052A (en) Compositions for anti-oxidant and anti-diabetic comprising extracts of bitter melon fermented with Leuconostoc mesenteroides
JP4833502B2 (en) Antioxidant composition
KR20160021734A (en) Antioxidative composition comprising extract of red tea stem
CN114272273A (en) NMN-containing antioxidant composition and preparation method thereof
JP2012121858A (en) Method for efficiently extracting and purifying active ingredient in geranium thunbergii with high purity, and creation of dpph radial complementary agent, sod activity-like agent, melanine synthesis inhibitor, discoloring preventing agent and enzyme inhibitor using the active ingredient
Makri et al. Biofunctional feed supplemented with by-products of olive oil production improves tissue antioxidant profile of lambs
KR20110025574A (en) Food composition comprising one or more selected from garlic, black garlic, onion, ginseng, and red ginseng and one or more selected from casein phosphopeptide-h (mix-pep.), beta casein-h, milk including beta casein-h, and yogurt prepared by fermenting milk including beta casein-h
Zulaikhah et al. The impact of tender coconut water on preventing lipid peroxidation and increasing antioxidant enzymes in lead-induced rats
CN110314116B (en) Synergistic antioxidant oral care composition and application thereof
JP5865524B2 (en) Method for producing gennoshouko composition
Ntite et al. Ameliorative effect of Combretum dolichopentalum in CCl4-induced oxidative stress
HM O et al. Aluminium toxicity in rats: The role of tannic acid as antioxidant
KR102475055B1 (en) Hypochlorous acid drinking composition
JP2001302530A (en) Reduction type antioxidant and method for producing the same
JP4786028B2 (en) Antiallergic agent
EP4032537A1 (en) Composition for elongating telomeres
Akkoyun et al. PROTECTIVE EFFECT OF ASTAXANTHIN AGAINST ALUMINUM INDUCED LIVER OXIDATIVE DAMAGE

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080125

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20091014

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7422

Effective date: 20091014

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20091014

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101220

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110214

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110217

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110318

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20110322

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20110825

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111125

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20111128

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20111219

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120202

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120307

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120326

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120406

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150413

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4971597

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250